Curtis Lockshin

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Xenetic Biosciences (United States)(Current)

Curtis Lockshin is an author at Xenetic Biosciences (United States) specializing in drug delivery, multiple sclerosis immunopathogenesis, and multiple sclerosis immunopathology.

Publications per year

2016–2018

Publications

CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

Alexey A. Belogurov, Yakov A. Lomakin, Kirill G Surkov et al. · Neurotherapeutics · 2016 · 37 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Clinical Application of Polysialylated Deoxyribonuclease and Erythropoietin

Meng He, Sanjay Jain, Curtis Lockshin et al. · Recent Patents on Drug Delivery & Formulation · 2018 · 15 citations

Engineering, Biotechnology, Pharmaceutical Biotechnology +9

1–2 of 2